Catalyst Wire Dossier Catalyst Wire Dossier

Elidel® Cream, 1%

pimecrolimus · Novartis
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Elidel® Cream, 1%, covering 2020-03-17 to 2020-03-17. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence Study of Pimecrolimus Cream, 1% and Elidel® Cream, 1% in Mild to Moderate Atopic Dermatitis [Phase 3]

See pricing